These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 2568767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M, Abdulatif M, al-Ghamdi A.
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF.
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M, Riad W.
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [Abstract] [Full Text] [Related]

  • 7. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
    Caldwell JE, Robertson EN, Baird WL.
    Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681
    [Abstract] [Full Text] [Related]

  • 8. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM, McChristian JW, Miller RD, Taboada JA, Cronnelly R.
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M, Abdulatif M, al-Ghamdi A, Hamo I, Nouheid R.
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [Abstract] [Full Text] [Related]

  • 12. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
    Kopman AF.
    Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
    [Abstract] [Full Text] [Related]

  • 13. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K.
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [Abstract] [Full Text] [Related]

  • 14. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M, Vilardi V, Fierro G, Rosa G, Pelaia P, Gasparetto A.
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ, Hoton F, D'Hollander AA, Cantraine FR.
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.